Juno Therapeutics, Inc. Business Finance Contracts & Agreements
12 Contracts & Agreements
- Investor Rights Agreements (5 contracts)
- Registration Rights Agreements (1)
- Share Agreements (3)
- Stock Agreements (1)
- Underwriting Agreements (2)
- Amendment No. 3 and Waiver of Fourth Amended and Restated Investors Rights Agreement, dated September 21, 2017 (Filed With SEC on November 1, 2017)
- Share Purchase Agreement and Omnibus Amendment by and between Juno Therapeutics, Inc., Celgene Corporation and certain of its affiliates, dated September 21, 2017 (Filed With SEC on September 22, 2017)
- Underwriting Agreement by and among Juno Therapeutics, Inc., Morgan Stanley & Co. LLC and J.P. Morgan Securities LLC, dated September 21, 2017 (Filed With SEC on September 22, 2017)
- JUNO THERAPEUTICS, INC. SECOND AMENDMENT to FOURTH AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (Filed With SEC on February 29, 2016)
- AMENDMENT AND WAIVER OF FOURTH AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT OF JUNO THERAPEUTICS, INC. July 27, 2015 (Filed With SEC on August 14, 2015)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on June 29, 2015)
- SHARE PURCHASE AGREEMENT (Filed With SEC on June 29, 2015)
- SHARE PURCHASE AGREEMENT related to PROJECT SPYDER 1 TABLE OF CONTENTS (Filed With SEC on May 11, 2015)
- JUNO THERAPEUTICS, INC. 2014 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on December 9, 2014)
- JUNO THERAPEUTICS, INC. FOURTH AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT December 5, 2014 TABLE OF CONTENTS (Filed With SEC on December 9, 2014)
- Shares JUNO THERAPEUTICS, INC. COMMON STOCK, PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENT (Filed With SEC on December 9, 2014)
- JUNO THERAPEUTICS, INC. THIRD AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT August 1, 2014 TABLE OF CONTENTS (Filed With SEC on November 17, 2014)